アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
The antiserum was produced against synthesized phosphopeptide derived from human 4EBP1 around the phosphorylation site of threonine 45 (S-T-TP-P-G).
Our Abpromise guarantee covers the use of ab47367 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Predicted molecular weight: 13 kDa.|
|IHC-P||Use at an assay dependent concentration.|
ab47367 has not yet been referenced specifically in any publications.